Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy

NCT04668937 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT04668937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04668937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
March 18, 2020
Completion date
June 30, 2020
Enrollment
11,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

number of patients during the studying period, reason for consultation